MOTIVE
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that “MOTIVE” is an abandoned application (status dead) that was filed by CSL Behring L.L.C. on Dec 15 2017 and officially abandoned on Jul 5 2021 because no Statement of Use was filed after the Notice of Allowance. The goods and services listed are limited to printed publications, newsletters and online material, and scientific‑technology services related to clinical trials, biotherapies, blood conditions and rare diseases (classes 016, 041 and 042). A similar name used in the same health‑research or educational publishing context would be the closest record‑based concern, while uses outside those fields are farther from the scope shown. The prosecution history shows the application moved through the usual intent‑to‑use steps, receiving a Notice of Allowance and several extensions before abandonment, but it never reached registration on the Supplemental Register. The latest meaningful event is the abandonment notice on Jul 5 2021, and the supplied history contains no opposition, cancellation or court actions. I'd treat this as a moderate concern if you plan a name in the same scientific‑education niche.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Dec 15, 2017 |
| Published for opposition | Apr 03, 2018 |
| Notice of Allowance | May 29, 2018 |
| Status date | Jul 05, 2021 |
Goods & services
Printed publications, namely, brochures, booklets, and teaching materials in the field of clinical trials for pharmaceutical preparations; Printed publications, namely, brochures, booklets, and teaching materials in the field of biotherapies, blood conditions, and rare diseases via the Internet
Publication of newsletters, magazines, periodicals, journals and case studies and on-line newsletters, magazines periodicals, journals and case studies containing the results of clinical trials for pharmaceutical preparations; Dissemination of printed educational material in the field of healthcare
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical research and scientific research information in the fields of biotherapies, blood conditions, and rare diseases via the Internet; Providing medical and scientific research information in the fields of pharmaceuticals; Providing a website featuring educational information in the field of clinical research; Providing medical and scientific research information in the field of clinical trials
Madrid Protocol · §66(a)
| Intl. registration no. | 1422230 |
Owner & representation
| Owner | CSL Behring L.L.C. |
| Address | 1020 First Avenue, King of Prussia, PENNSYLVANIA UNITED STATES 19406 |
| Entity | LIMITED LIABILITY COMPANY - organized in DELAWARE |
| Attorney of record | Scott D. Woldow |
| Correspondent | Scott D. Woldow |
| Attorney email | s********@*****.com |
| Correspondent email | 2 emails |
| Correspondent phone | 2********0 |
| Correspondent address | WASHINGTON, DISTRICT |